“The new framework will strengthen the MHRA’s ability to keep patients safe, while at the same time contributing to an environment which encourages the launch of the most innovative healthcare products that make a real difference to the public’s health. The roadmap sets out how we will work with stakeholders, including patients, as the process moves forward.”
Even AI models trained on general medical literature will have difficulty making sense of the nuances specific to primary care, which is full of unique jargon, abbreviations and other idiosyncrasies. As always, the proverbial devil is in the details. Any AI solution worth its salt must be fluent in the specific idioms of the field and empower clinicians to deliver the best care that they can.
A recent survey by the AMA showed that practicing physicians are equally excited and concerned about the increased use of AI in health care, with enthusiasm for technologies that reduce administrative burden and enhance diagnostic ability and concern for patient privacy, liability and erosion of the patient-physician relationship.
Decoding the legal framework for faster time-to-market.
Peter J. Arduini, president and CEO of GE HealthCare, began his two-year term as Board Chair last Friday. The same day AdvaMed announced its new Medical Imaging Division under the direction of Patrick Hope, former executive director of the Medical Imaging & Technology Alliance.
Patient adherence is critical to maximizing the benefits of medical wearables. In this article, we look at the key challenges to patient adherence in clinical trials and healthcare settings, and how device developers, researchers and providers can collaborate to harness the full benefits of wearables.
The convergence of gamification and AI heralds a transformative era in mental health care, offering a blend of engagement and precision previously unattainable.
AI-driven regulatory platforms support SaMD organizations by proactively monitoring and adapting to the dynamic global regulatory landscape. The technology alerts users to anticipated regulatory updates worldwide, facilitating improved foresight and trend detection. It also provides guidance on addressing potential lapses in product compliance, integrates with existing workflows and streamlines regulatory tasks from classification to registration and market entry.
On October 30, President Biden issued an Executive Order establishing new standards for artificial intelligence (AI). The order focuses on safety and security, privacy protections, advancement of equity and civil rights, promotion of innovation and competition and advancing American leadership in AI.
While billion-dollar deals are common in the medtech industry, multi-billion-dollar megadeal acquisitions were still notable in 2022. Often, these deals result in a ripple effect on the industry when two large companies merge. Here we look at some recent examples, the growth drivers behind them and what they mean for the medtech industry.
